Research Topic · Peer-Reviewed

Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma is an aggressive and deadly form of cancer that starts in the cells of the pancreas. It is the fourth leading cause of cancer-related deaths in the United States, due to its tendency to spread quickly and its difficulty to detect in the early stages. Symptoms can include abdominal pain, wei…

Curated from this journal's research 📚 6 peer-reviewed articles cited Cited 10× across the literature 🗓 Reviewed June 2026

Overview

Pancreatic Adenocarcinoma is an aggressive and deadly form of cancer that starts in the cells of the pancreas. It is the fourth leading cause of cancer-related deaths in the United States, due to its tendency to spread quickly and its difficulty to detect in the early stages. Symptoms can include abdominal pain, weight loss, yellowing of the skin, and fatigue. Treatment options include chemotherapy, radiation, and surgery. With early detection and treatment, survival rates can be improved and quality of life can be extended for those affected by Pancreatic Adenocarcinoma.

Research published in this journal

6 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 6 articles above have been cited 10 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Pancreatic Adenocarcinoma, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Pancreas.

Journal editorial board
Giuseppe Maulucci · Italy Carlo Molino · United States Cosimo Sperti · Italy

This page summarises published research for orientation; it is not medical or professional advice.